Recursion Pharmaceuticals
clinical preclinical studies reduces lesion burden and ameliorates vascular defects in genetic mouse models of further confidence confirm insight | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
92 of 143
Related slides by other companies
Arbutus Biopharma
Investor Presentation
March 2023
reduces in mouse model | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
August 2023
reduces in mouse model | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
May 2023
reduces in mouse model | Arbutus Biopharma
Equillium
Investor Presentation
February 2024
reverses immune mediated hair loss in a mouse model | Equillium
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io